Rongge Jiang

Feb 5, 2024 | dovepress.com | Xue Jiang |Ding Wang |Rongge Jiang |Haibai Liu

IntroductionBreast cancer constitutes a prevalent malignancy among women, representing approximately 7%–10% of all malignant tumors and ranking second only to cervical cancer. This disease poses a substantial threat to the lives of women and overall health.1,2 Postoperative brain metastasis resulting from breast cancer is frequently encountered in clinical practice, emerging as the second most prevalent source of brain metastatic tumors.